Cargando…
Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793248/ https://www.ncbi.nlm.nih.gov/pubmed/36582427 http://dx.doi.org/10.2147/NDT.S399627 |
_version_ | 1784859814058262528 |
---|---|
author | Oguchi, Yoshiyo |
author_facet | Oguchi, Yoshiyo |
author_sort | Oguchi, Yoshiyo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9793248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97932482022-12-28 Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] Oguchi, Yoshiyo Neuropsychiatr Dis Treat Letter Dove 2022-12-22 /pmc/articles/PMC9793248/ /pubmed/36582427 http://dx.doi.org/10.2147/NDT.S399627 Text en © 2022 Oguchi. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Oguchi, Yoshiyo Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title | Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title_full | Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title_fullStr | Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title_full_unstemmed | Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title_short | Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter] |
title_sort | impact of the covid-19 pandemic on medication adherence and maintenance treatment for schizophrenia: a reconsideration [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793248/ https://www.ncbi.nlm.nih.gov/pubmed/36582427 http://dx.doi.org/10.2147/NDT.S399627 |
work_keys_str_mv | AT oguchiyoshiyo impactofthecovid19pandemiconmedicationadherenceandmaintenancetreatmentforschizophreniaareconsiderationletter |